Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPROST vs IMIGLUCERASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ILOPROST vs IMIGLUCERASE: Safety Overview

Metric ILOPROST IMIGLUCERASE
Total FAERS Reports 4,961 2,564
Deaths Reported 2,277 322
Death Rate 45.9% 12.6%
Hospitalizations 2,324 549
Average Patient Age 57.9 yrs 36.4 yrs
% Female Patients 70.7% 62.7%
FDA Approval Date Aug 7, 2009 N/A
Manufacturer BTG International Inc Genzyme Corporation
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription